Back
Lyell Immunopharma, Inc. Stock Predictions
The Next Phase of AI Is Not About Chat
*DISCLOSURE: This is a paid advertisement for Immersed Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks immersed.com
Sell
44
LYEL
Lyell Immunopharma, Inc.
Last Price:
$22.73
Seasonality Move:
-5.66%
7 Day Trial
ALL ACCESS PASS
$
7
When an AI Platform Gets Pulled by Too Much Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiLyell Immunopharma, Inc. Stock Forecast
-
Over the next 52 weeks, Lyell Immunopharma, Inc. has on average historically fallen by 17.5% based on the past 4 years of stock performance.
-
Lyell Immunopharma, Inc. has fallen lower in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
-
Is Lyell Immunopharma, Inc. Stock Undervalued?The current Lyell Immunopharma, Inc. [LYEL] share price is $22.71. The Score for LYEL is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
LYEL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Lyell Immunopharma, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Lyell Immunopharma, Inc. has on average historically fallen by 17.5% based on the past 4 years of stock performance.
Lyell Immunopharma, Inc. Stock Rating
Sell
44
Lyell Immunopharma, Inc. (LYEL)
is a Sell
Is Lyell Immunopharma, Inc. overpriced?
-
Lyell Immunopharma, Inc. has fallen lower in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
Lyell Immunopharma, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
lyell.com
52-Week Data
52-Week High:
45.00
52-Week Low:
7.65
Prediction Charts
Market Cap:
336.3M
Price in USD:
22.71
Volume:
124.6K
Beta:
-0.14
Technical Analysis
SMA50:
27.39
SMA100:
21.97
SMA200:
16.05
52-Wk Change:
92.13%
Stock Predictions
-
Is Lyell Immunopharma, Inc. stock public?Yes, Lyell Immunopharma, Inc. is a publicly traded company.
-
What is the Lyell Immunopharma, Inc. stock quote today?The Lyell Immunopharma, Inc. stock price is 22.71 USD today.
-
How to buy Lyell Immunopharma, Inc. stock online?You can buy Lyell Immunopharma, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-20 | 23.20 | 23.90 | 24.33 | 22.67 |
| Jan-21 | 23.93 | 24.12 | 25.00 | 23.51 |
| Jan-22 | 24.41 | 25.84 | 27.89 | 24.22 |
| Jan-23 | 25.81 | 25.26 | 25.92 | 24.87 |
| Jan-26 | 25.02 | 24.90 | 25.84 | 24.57 |
| Jan-27 | 25.03 | 25.28 | 26.02 | 24.73 |
| Jan-28 | 25.25 | 24.03 | 26.01 | 24.03 |
| Jan-29 | 24.03 | 24.81 | 25.41 | 24.00 |
| Jan-30 | 24.52 | 24.00 | 25.05 | 23.00 |
| Feb-2 | 24.00 | 24.77 | 25.44 | 23.79 |
| Feb-3 | 24.58 | 25.77 | 26.76 | 24.53 |
| Feb-4 | 25.76 | 24.18 | 25.76 | 23.74 |
| Feb-5 | 23.50 | 22.64 | 24.92 | 22.00 |
| Feb-6 | 22.65 | 22.71 | 23.73 | 22.30 |
Lyell Immunopharma, Inc. Earnings
Lyell Immunopharma, Inc. Earnings Report: Per Share Lyell Immunopharma, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Lyell Immunopharma, Inc. Forecast Revenue Growth
Lyell Immunopharma, Inc. Stock Analysis: Historical quarterly revenues per share for Lyell Immunopharma, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.96 per share, and a decrease next year of $0.00 per share.
* Lyell Immunopharma, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.